Thromboprophylaxis with standard-dose vs. flexible-dose heparin for hospitalized COVID-19 patients: a target trial emulation

Martínez-Alés, G., Domingo-Relloso, A., Quintana-Díaz, M., Fernández-Capitán, C., & Hernán, M. A. (2022). Thromboprophylaxis with standard-dose vs. flexible-dose heparin for hospitalized COVID-19 patients: a target trial emulation. Journal of Clinical Epidemiology, 151, 96–103. https://doi.org/10.1016/j.jclinepi.2022.08.006
Authors:
Gonzalo Martínez-Alés
Arce Domingo-Relloso
Manuel Quintana-Díaz
Carmen Fernández-Capitán
Miguel A Hernán
Affiliated Authors:
Arce Domingo-Relloso
Columbia Affiliation:
Subjects:
COVID-19 (MeSH)
Venous Thromboembolism (MeSH)
Thrombosis (MeSH)
Author Keywords:
anticoagulants
covid-19
covid-19 drug treatment
epidemiological methods
low-molecular weight heparin
target trial emulation
low–molecular weight heparin
elink
Publication Type:
Article
Unique ID:
10.1016/j.jclinepi.2022.08.006
PMID:
35987402
DOI:
10.1016/j.jclinepi.2022.08.006
Journal:
Journal of Clinical Epidemiology
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record
View Web of Science Record

Record Created: